PD/L-1 INHIBITORS MARKET: GROWTH TRENDS, LEADING COMPANIES, AND FUTURE PROSPECTS

The PD/L-1 Inhibitors Market has experienced remarkable growth in recent years, driven by innovations in immunotherapy and the rising global cancer burden. PD-1 (programmed cell death protein 1) and PD-L1 (programmed death-ligand 1) inhibitors have revolutionized cancer treatment by leveraging the immune system to target and eliminate cancer cells.